Literature DB >> 4479392

[Studies on the spontaneous decomposition of 4-hydroxyphosphamide and 4-hydroperoxyphosphamide by means of thin-layer chromatography].

G Völker, U Dräger, G Peter, H J Hohorst.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4479392

Source DB:  PubMed          Journal:  Arzneimittelforschung        ISSN: 0004-4172


× No keyword cloud information.
  17 in total

1.  In-vitro testing of cyclophosphamide on tumors.

Authors:  M Kaufmann; J Mattern; M Volm; H J Hohorst; G Peter; G Vollcker
Journal:  Naturwissenschaften       Date:  1975-09

2.  Proton magnetic resonance studies of the decomposition of 4-hydroxycyclophosphamide, a microsomal metabolite of cyclophosphamide.

Authors:  E J Valente; K K Chan; K L Servis
Journal:  Pharm Res       Date:  1984-03       Impact factor: 4.200

3.  [On the binding of cyclophosphamide and cyclophosphamide-metabolites to serum-albumin (author's transl)].

Authors:  G Voelcker; H P Giera; L Jäger; H J Hohorst
Journal:  Z Krebsforsch Klin Onkol Cancer Res Clin Oncol       Date:  1978-05-31

4.  Formation, toxicity and inactivation of acrolein during biotransformation of cyclophosphamide as studied in freshly isolated cells from rat liver and kidney.

Authors:  Y Ohno; K Ormstad
Journal:  Arch Toxicol       Date:  1985-06       Impact factor: 5.153

5.  [The evaluation of the cyclophosphamide sensitivity of human tumours by determining the incorporation of tritiated uridine and thymidine into the nucleic acids of human tumor cells in vitro in presence of 4-hydroxycyclophosphamide (author's transl)].

Authors:  G Bastert; H Schmidt-Matthiesen; G Voelcker; G Peter; H J Hohorst
Journal:  Z Krebsforsch Klin Onkol Cancer Res Clin Oncol       Date:  1975-09-22

6.  Comparative study on human pharmacokinetics of activated ifosfamide and cyclophosphamide by a modified fluorometric test.

Authors:  T Wagner; D Heydrich; T Jork; G Voelcker; H J Hohorst
Journal:  J Cancer Res Clin Oncol       Date:  1981       Impact factor: 4.553

7.  Detection of induced tumour-resistance to cyclophosphamide by the in vitro short term test.

Authors:  M Volm; J Mattern; K Wayss
Journal:  Arch Gynakol       Date:  1977-11-29

8.  Preclinical pharmacokinetics and stability of isophosphoramide mustard.

Authors:  J J Zheng; K K Chan; F Muggia
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

9.  [Blood level and urinary excretion of activated cyclophosphamide and its deactivation products in man (author's transl)].

Authors:  T Wagner; D Heydrich; G Voelcker; H J Hohorst
Journal:  J Cancer Res Clin Oncol       Date:  1980-01       Impact factor: 4.553

10.  Detection of induced resistance in short-term-tests. Adriamycin-resistant sarcoma 180.

Authors:  M Volm; C Lindner
Journal:  Z Krebsforsch Klin Onkol Cancer Res Clin Oncol       Date:  1978-01-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.